A product investigation was performed for this device.The actual device was not returned for evaluation.A review of the device history record was performed.There were no unexpected variances, adjustments or comments noted in the device record.A review was performed by the post market clinical department.Per the pharmacovigilance associate medical director, it is unlikely that the pd products were causally related to the patient's death.The patient had severe aortic stenosis, hypotension, with negative peritoneal cultures.The products in question were subject to recall because of an increased incidence of leaks developing during treatment.The fluid path of these products is sterile in the absence of a leak.The information available does not mention the presence or occurence of fluid leaks and the patient was reported to have had negative peritoneal dialysate cultures.This is a retrospective mdr being submitted by fresenius medical care as a remediation action committed to fda regarding all potential adverse events received between (b)(6) 2011 to (b)(6) 2013.
|